Skip to main content
FinSpry Logo
FinSpry
ZTS logo
ZTS
(NYSE)
Zoetis Inc.
$78.92-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Zoetis (ZTS) Stock Price & Financial Analysis

Zoetis Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$77.25 - $80.44
52-Week High$172.23
52-Week Low$75.11
Open$78.47
Volume6.93M
Average Volume (3M)6.59M
Market Cap34.09B
Shares Outstanding438.60M
P/E Ratio (TTM)12.18
Forward P/E12.00
Price to Sales (P/S)3.44
Price to Book (P/B)9.77
EV/EBITDA9.67
Revenue (TTM)9.47B
Net Income (TTM)2.67B
Free Cash Flow (TTM)2.28B
EPS (TTM)$6.02
Profit Margin28.23%
Operating Margin38.00%
Return on Equity (ROE)80.25%
Debt to Equity2.73
50-Day MA$115.02
200-Day MA$130.23
52-Week Change-52.65%
Annual Dividend$2.06
Dividend Yield2.65%
Payout Ratio34.20%
Last Dividend Ex-DateApr 20, 2026

Frequently Asked Questions About Zoetis

What is the current stock price for ZTS?

As of the latest trading session, ZTS stock trades at $79.71. The 52-week range is $75.11–$172.23, with a day range of $77.25–$80.44.

What is the P/E ratio for ZTS?

Zoetis's trailing P/E ratio is 12.2, meaning investors pay $12.2 for every $1 of annual earnings. The forward P/E is 12.0, reflecting analyst expectations for future earnings. Zoetis operates in the Healthcare sector.

Does ZTS pay dividends?

Yes, Zoetis pays a 2.65% annual dividend yield ($2.06 per share). The payout ratio is 34.2%. The last ex-dividend date was 2026-04-20.

What do analysts recommend for ZTS?

Based on 2 analysts, the consensus for ZTS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ZTS?

Zoetis's market capitalization is $34.96B, classifying it as a large-cap company. Zoetis operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.